These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2097709)

  • 1. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():209-17. PubMed ID: 2097709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular distribution and activity of antibiotics.
    Tulkens PM
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):100-6. PubMed ID: 1864271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
    Tulkens PM
    Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolides and the immune system.
    McDonald PJ; Pruul H
    Scand J Infect Dis Suppl; 1992; 83():34-40. PubMed ID: 1488627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
    Seral C; Carryn S; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections.
    Baudoux P; Bles N; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2007 Feb; 59(2):246-53. PubMed ID: 17220162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages.
    Barcia-Macay M; Seral C; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):841-51. PubMed ID: 16495241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
    J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF 3013 against Klebsiella pneumoniae.
    Tullio V; Cuffini AM; Bonino A; Ianni Palarchio A; Rossi V; Carlone NA
    Drugs Exp Clin Res; 1999; 25(1):1-11. PubMed ID: 10337499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens.
    Schaper KJ; Schubert S; Dalhoff A
    Infection; 2005 Dec; 33 Suppl 2():3-14. PubMed ID: 16518706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotics, developments and orientation].
    de Marie S; Verbrugh HA
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):673-8. PubMed ID: 1560853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic and biochemical basis of microbial resistance to antibiotics].
    Popović M; Delić V
    Lijec Vjesn; 1990; 112(7-8):250-7. PubMed ID: 2292900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus.
    Nguyen HA; Grellet J; Dubois V; Saux MC; Quentin C
    J Antimicrob Chemother; 2007 Apr; 59(4):755-8. PubMed ID: 17353222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics for acute orofacial infections.
    Pallasch TJ
    J Calif Dent Assoc; 1993 Feb; 21(2):34-44. PubMed ID: 7693890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.